The company maintains a thin capital structure with $2.5 billion in equity supporting $38.9 billion in total assets as of 2026Q1, highlighting potential sensitivity to reserve strengthening.
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 | Dec'02 |
|---|
| Total Assets | 38.9B | 38.79B | 37.85B | 35.03B | 33.13B | 36.2B | 35.34B | 33.63B | 31.44B | 33.11B | 31.98B | 31.13B | 31.18B | 34.78B | 34.13B | 33.33B | 31.9B | 30.34B | 28.77B | 33.51B | 32.72B | 31.56B | 30.76B | 29.92B | 46.51B |
| Asset Growth % | 11.47% | 2.49% | 8.06% | 5.72% | -8.48% | 2.45% | 5.08% | 6.97% | -5.05% | 3.55% | 2.73% | -0.19% | -10.34% | 1.9% | 2.4% | 4.49% | 5.13% | 5.47% | -14.16% | 2.44% | 3.68% | 2.61% | 2.79% | -35.67% | - |
| Total Investment Assets | 4M | 30B | 27.87B | 768.6M | 24.34B | 51.17B | 27.58B | 25.58B | 23B | 27.85B | 26.24B | 24.49B | 24.91B | 27.15B | 27.96B | 24.28B | 21.07B | 18.85B | 15.64B | 20.55B | 22.83B | 22.52B | 21.67B | 19.91B | 19.57B |
| Long-Term Investments | 86.09B | 22.08B | 4.84B | -20.74B | 3.78B | 26.36B | 24.96B | 22.77B | 20.44B | 25.23B | 23.77B | 22.24B | 22.67B | 24.72B | 25.87B | 24.28B | 21.07B | 18.85B | 15.64B | 20.55B | 22.83B | 22.52B | 21.67B | 19.91B | 19.57B |
| Short-Term Investments | 8.26B | 7.92B | 23.03B | 21.51B | 20.56B | 24.81B | 23.38B | 21.3B | 18.45B | 22.91B | 21.1B | 19.88B | 20.63B | 23.18B | 24.61B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Current Assets | 1.15B | 13.58B | 29.99B | 0 | 26.73B | 29.38B | 0 | 0 | 594M | 578M | 478M | 432M | 611M | 699M | 582M | 436M | 571M | 523M | 894.5M | 4.02B | 1.26B | 1.16B | 1.77B | 2.19B | 2.2B |
| Cash & Equivalents | 1.13B | 956.1M | 1.66B | 774.5M | 69.2M | 99.6M | 54.1M | 74.7M | 62.4M | 178.9M | 189.3M | 364.4M | 68.3M | 104.3M | 54.2M | 510.4M | 571.9M | 523.4M | 894.5M | 428.6M | 409.9M | 273M | 795.5M | 1.26B | 1.27B |
| Receivables | 18.83B | 4.68B | 4.96B | 4.98B | 5.52B | 4.47B | 4.78B | 5.22B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3.59B | 850.8M | 887.5M | 975.7M | 930.5M | 934.2M |
| Other Current Assets | -12.88B | 27.4M | 341M | -27.26B | 575.7M | 632.1M | -28.22B | -26.59B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill & Intangibles | 7.51B | 2.54B | 2.32B | 2.13B | 1.97B | 1.33B | 0 | 0 | 1.67B | 1.39B | 1.45B | 1.53B | 1.26B | 1.65B | 1.26B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.11B | 100M |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 952.2M | 100M |
| Intangible Assets | 2.58B | 2.54B | 2.32B | 2.13B | 1.97B | 1.33B | 0 | 0 | 1.67B | 1.39B | 1.45B | 1.53B | 1.26B | 1.65B | 1.26B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 155.2M | 0 |
| PP&E (Net) | 0 | 0 | 0 | 85.3M | 0 | 48.2M | 0 | 0 | -2.7B | -1.39B | -3.09B | -3.22B | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 12.71B | 590.9M | 703.2M | 52.42B | 648.8M | -1.38B | -24.96B | -22.77B | -12.86B | -20.56B | -18.75B | -16.27B | -18.5B | -19.73B | -21.82B | -18.04B | -13.86B | -18.85B | -15.64B | -20.55B | -22.83B | -22.52B | -21.67B | -21.02B | -19.67B |
| Total Liabilities | 36.47B | 36.15B | 35.33B | 32.81B | 31.36B | 30.94B | 29.86B | 28.95B | 28.07B | 28.26B | 27.49B | 26.99B | 26.5B | 29.83B | 29.08B | 28.3B | 27.57B | 26.81B | 27.15B | 29.28B | 28B | 27.04B | 26.85B | 27.1B | 48.56B |
| Total Debt | 4.3B | 4.05B | 4.52B | 4.15B | 3.88B | 4B | 3.93B | 3.79B | 3.98B | 3.97B | 4.22B | 4.14B | 3.6B | 3.77B | 3.42B | 3.05B | 2.2B | 1.72B | 2.1B | 2.11B | 1.42B | 1.17B | 1.19B | 1.69B | 669.7M |
| Net Debt | 3.17B | 3.1B | 2.86B | 3.38B | 3.81B | 3.9B | 3.88B | 3.71B | 3.92B | 3.79B | 4.03B | 3.77B | 3.53B | 3.66B | 3.37B | 2.54B | 1.63B | 1.2B | 1.2B | 1.68B | 1.01B | 893.6M | 397.3M | 426.7M | -599.2M |
| Long-Term Debt | 4.3B | 4.05B | 4.52B | 4.15B | 3.88B | 4B | 3.93B | 3.79B | 3.98B | 3.97B | 4.22B | 4.14B | 3.57B | 3.77B | 3.42B | 3.05B | 2.59B | 1.72B | 2.1B | 2.11B | 1.42B | 851.5M | 1.2B | 1.69B | 669.7M |
| Short-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.04B | 0 | 0 | 0 | 315.1M | 0 | 0 | 0 |
| Total Current Liabilities | 19.22B | 19.14B | 17.82B | 0 | 15.47B | 8.4M | 0 | 0 | 24.09B | 24.29B | 23.27B | 22.85B | 22.9B | 26.06B | 28.08B | 27.44B | 26.57B | 25.77B | 25.82B | 28.09B | 27B | 26.19B | 26.09B | 25.8B | 0 |
| Accounts Payable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 590.3M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 225.2M | 228M | 226.8M | 0 | 235M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 19B | 18.91B | 17.59B | 0 | 15.23B | 8.4M | 0 | 0 | 24.09B | 24.29B | 23.27B | 22.85B | 0 | 25.47B | 0 | 0 | 0 | -1.04B | 0 | 0 | 0 | -322.9M | 0 | 0 | 0 |
| Deferred Taxes | 236.1M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1000K | 1000K | 1000K | 1000K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Liabilities | 32.1B | 12.96B | 12.99B | 28.66B | 12.01B | 13.01B | -3.93B | -3.79B | 0 | 0 | 0 | 0 | 28.6M | 25.61B | 25.68B | -3.05B | -2.59B | -1.72B | -2.1B | -2.11B | -1.42B | -851.5M | -1.2B | -1.69B | -669.7M |
| Total Equity | 2.5B | 2.64B | 2.52B | 2.22B | 1.77B | 5.26B | 5.48B | 4.68B | 3.37B | 4.85B | 4.49B | 4.14B | 4.69B | 4.96B | 5.05B | 5.03B | 4.33B | 3.53B | 1.62B | 4.24B | 4.71B | 4.52B | 3.9B | 2.82B | -2.05B |
| Equity Growth % | 4.63% | 4.89% | 13.52% | 25.26% | -66.37% | -4.09% | 17.26% | 38.75% | -30.46% | 8.04% | 8.42% | -11.73% | -5.39% | -1.86% | 0.33% | 16.35% | 22.45% | 118.16% | -61.77% | -10.13% | 4.28% | 15.83% | 38.49% | 237.42% | - |
| Shareholders Equity | 2.5B | 2.64B | 2.52B | 2.22B | 1.77B | 5.26B | 5.48B | 4.68B | 3.37B | 4.85B | 4.49B | 4.14B | 4.69B | 4.96B | 5.05B | 5.03B | 4.33B | 3.53B | 1.62B | 4.24B | 4.71B | 4.52B | 3.9B | 2.82B | -2.05B |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings | 2.44B | 2.42B | 2.25B | 1.9B | 1.69B | 1.13B | 752.3M | 535.7M | 196.6M | 765.8M | 650.7M | 347.1M | 128.5M | 128.4M | -325M | 42.8M | -339.7M | -614.6M | -688M | 438.7M | 643.2M | 584.7M | 297.8M | 68.5M | -6.63B |
| Common Stock | 900K | 900K | 1M | 1.1M | 1.1M | 1.2M | 1.3M | 1.5M | 1.6M | 1.7M | 1.7M | 1.8M | 2M | 2.2M | 2.2M | 2.4M | 2.5M | 2.5M | 1.9M | 1.9M | 1.5M | 1.5M | 1.5M | 1M | 3.5B |
| Accumulated OCI | -1.22B | -1.11B | -1.37B | -1.58B | -1.96B | 1.95B | 2.19B | 1.37B | 177.7M | 1.01B | 622.4M | 402.8M | 825.3M | 731.8M | 1.2B | 625.5M | 238.3M | -264.3M | -1.77B | -273.3M | -72.6M | 71.7M | 337.3M | 218.7M | 580.6M |
| Return on Equity (ROE) | 9.56% | 8.9% | 17.08% | 13.88% | 17.94% | 10.62% | 5.94% | 10.17% | -7.67% | 3.76% | 8.31% | 6.13% | 1.07% | 9.56% | 4.38% | 7.17% | 7.24% | 3.33% | -38.68% | -4.02% | 2.3% | 7.43% | 8.62% | 599.06% | - |
| Return on Assets (ROA) | 0.64% | 0.6% | 1.11% | 0.81% | 1.82% | 1.59% | 0.88% | 1.26% | -0.98% | 0.54% | 1.14% | 0.87% | 0.16% | 1.39% | 0.66% | 1.03% | 0.91% | 0.29% | -3.64% | -0.54% | 0.33% | 1% | 0.95% | 6.01% | -16.85% |
| Equity / Assets | 6.42% | 6.8% | 6.65% | 6.33% | 5.34% | 14.53% | 15.52% | 13.91% | 10.72% | 14.64% | 14.03% | 13.3% | 15.03% | 14.25% | 14.79% | 15.1% | 13.56% | 11.64% | 5.63% | 12.64% | 14.41% | 14.32% | 12.69% | 9.42% | -4.41% |
| Debt / Equity | 1.72x | 1.54x | 1.80x | 1.87x | 2.20x | 0.76x | 0.72x | 0.81x | 1.18x | 0.82x | 0.94x | 1.00x | 0.77x | 0.76x | 0.68x | 0.61x | 0.51x | 0.49x | 1.29x | 0.50x | 0.30x | 0.26x | 0.31x | 0.60x | - |
| Book Value per Share | 26.56 | 26.99 | 23.26 | 19.25 | 15.03 | 40.11 | 38.31 | 29.76 | 20.37 | 28.16 | 25.16 | 21.21 | 21.54 | 21.29 | 17.94 | 16.55 | 14.33 | 18.27 | 8.77 | 24.43 | 30.90 | 24.43 | 26.80 | 28.14 | -20.48 |
| Tangible BV per Share | -0.88 | 1.00 | 1.81 | 0.79 | -1.75 | 29.93 | 38.31 | 29.76 | 10.30 | 20.11 | 17.05 | 13.35 | 15.75 | 14.21 | 13.48 | 16.55 | 14.33 | 18.27 | 8.77 | 24.43 | 30.90 | 24.43 | 26.80 | 17.08 | -21.48 |
Legacy LTC morbidity volatility
As reported in recent financial statements, CNO's total assets grew from $34.9 billion in 2024Q1 to $38.9 billion by 2026Q1, reflecting a steady expansion of the balance sheet that appears to be driven by both organic premium growth and the accumulation of long-duration insurance liabilities.
The consistent increase in total assets relative to liabilities suggests that the company is successfully managing its scale, though the modest equity base of $2.5 billion in 2026Q1 warrants caution regarding capital buffers. Investors should monitor whether this asset growth translates into sustainable capital generation or if it merely reflects the expansion of lower-margin, capital-intensive insurance blocks.
Based on CNO's reported figures, the loss ratio has fluctuated significantly, reaching a high of 69.2% in 2024Q3 before moderating to 55.4% in 2026Q1, which highlights the inherent difficulty in predicting long-term care morbidity and the potential for periodic reserve strengthening to impact the company's equity position.
The volatility in loss ratios suggests that actuarial assumptions remain sensitive to external morbidity trends, which may necessitate future reserve adjustments. This variability implies that the company's reported earnings may be subject to sudden, non-operational shocks that could temporarily impair the perceived strength of the balance sheet.
According to recent SEC filings, CNO maintains an equity base of $2.5 billion against $38.9 billion in total assets, indicating a thin capital cushion that may limit the company's flexibility to absorb significant adverse deviations in its legacy long-term care insurance portfolio without impacting shareholder value.
The relatively low equity-to-asset ratio suggests that the company operates with a high degree of leverage, which is typical for life insurers but requires disciplined capital management. Investors should consider whether the current capital levels are sufficient to support both the ongoing pivot toward fee-based advisory services and the potential for unexpected claims volatility.
As evidenced by the periodic spikes in the loss ratio, CNO's reliance on legacy long-term care blocks remains a primary risk factor, as these liabilities are inherently difficult to hedge and may require ongoing capital infusions that could constrain the company's ability to pursue aggressive share repurchases.
While management has taken steps to mitigate these risks through premium rate increases, the potential for morbidity trends to exceed actuarial expectations remains a non-obvious threat to the balance sheet. This exposure warrants further investigation into the sensitivity of the company's statutory capital to prolonged periods of elevated claims activity.
Quick answers to the most common questions about buying CNO stock.
As of 2025, CNO Financial Group, Inc. (CNO) had total assets of $38.79B including $13.58B in current assets.
CNO Financial Group, Inc. (CNO) carries total debt of $4.05B, offset by $8.87B in cash and short-term investments. Comparing total debt to cash helps evaluate the company's debt burden and net leverage.
CNO Financial Group, Inc. (CNO) has total shareholders' equity (book value) of $2.64B ($26.99 book value per share). Book value represents the net worth of the company belonging to common stock holders.
CNO Financial Group, Inc. (CNO) reported a current ratio of 0.71x. A current ratio above 1.0x indicates that the company has more current assets than current liabilities, suggesting sufficient short-term liquidity.